320 related articles for article (PubMed ID: 8053233)
21. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D
Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273
[TBL] [Abstract][Full Text] [Related]
22. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
de Bock GH; Putter H; Bonnema J; van der Hage JA; Bartelink H; van de Velde CJ
Breast Cancer Res Treat; 2009 Sep; 117(2):401-8. PubMed ID: 19148746
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between an appearance time of and a prognosis of recurrent patients of breast cancer].
Nishiguchi H; Yoda J; Hasegawa R; Okabe H; Sakazaki T; Murakami K
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):42-9. PubMed ID: 6739281
[No Abstract] [Full Text] [Related]
24. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing survival and recurrence-free intervals after treatment of primary breast cancer.
O'Higgins N; Brady HR; Clark CG
Ir Med J; 1984 Jul; 77(7):197-202. PubMed ID: 6469532
[No Abstract] [Full Text] [Related]
26. Adjuvant treatment in high-risk breast cancer.
Jones A
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):156-8. PubMed ID: 8777488
[No Abstract] [Full Text] [Related]
27. [The prognostic significance of intramammary recurrence in breast-conserving therapy].
Dunst J
Strahlenther Onkol; 1996 Apr; 172(4):233-4. PubMed ID: 8623089
[No Abstract] [Full Text] [Related]
28. [The time of intramammary recurrence after breast-preserving therapy is decisive for patient prognosis].
Fietkau R
Strahlenther Onkol; 1996 Dec; 172(12):696-7. PubMed ID: 8992642
[No Abstract] [Full Text] [Related]
29. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
30. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
Kunos C; Latson L; Overmoyer B; Silverman P; Shenk R; Kinsella T; Lyons J
Breast J; 2006; 12(1):28-36. PubMed ID: 16409584
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic strategy in breast cancer].
Florea I; Dragomirescu C; Aldea C; Mihai C; Lişcu B; Liţescu M; Pento V; Vizeteu R
Chirurgia (Bucur); 1995; 44(4):7-15. PubMed ID: 8646030
[TBL] [Abstract][Full Text] [Related]
32. Importance of nuclear morphology in breast cancer prognosis.
Wolberg WH; Street WN; Mangasarian OL
Clin Cancer Res; 1999 Nov; 5(11):3542-8. PubMed ID: 10589770
[TBL] [Abstract][Full Text] [Related]
33. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors in breast cancer--classification in non-university hospitals].
Willner J; Kiricuta IC; Kölbl O; Bohndorf W
Zentralbl Chir; 1993; 118(9):525-31. PubMed ID: 8237148
[TBL] [Abstract][Full Text] [Related]
35. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
36. Cancer of the breast. Local and regional recurrence.
Donegan WL
Major Probl Clin Surg; 1979; 5():484-503. PubMed ID: 379455
[No Abstract] [Full Text] [Related]
37. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
[No Abstract] [Full Text] [Related]
39. Strategy for breast conserving treatment--analysis of recurrence and prognosis after breast cosnserving treatment.
Shin E; Takatsuka Y; Okamura Y; Fukuda K; Mishima H; Tono T; Yagyu T; Kobayashi K; Kikkawa N; Takeda M; Kurata A; Otani M
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():92-9. PubMed ID: 8702319
[TBL] [Abstract][Full Text] [Related]
40. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
